Correlation Between Elicera Therapeutics and Idogen AB

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Elicera Therapeutics and Idogen AB at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Elicera Therapeutics and Idogen AB into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Elicera Therapeutics AB and Idogen AB, you can compare the effects of market volatilities on Elicera Therapeutics and Idogen AB and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Elicera Therapeutics with a short position of Idogen AB. Check out your portfolio center. Please also check ongoing floating volatility patterns of Elicera Therapeutics and Idogen AB.

Diversification Opportunities for Elicera Therapeutics and Idogen AB

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Elicera and Idogen is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Elicera Therapeutics AB and Idogen AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Idogen AB and Elicera Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Elicera Therapeutics AB are associated (or correlated) with Idogen AB. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Idogen AB has no effect on the direction of Elicera Therapeutics i.e., Elicera Therapeutics and Idogen AB go up and down completely randomly.

Pair Corralation between Elicera Therapeutics and Idogen AB

If you would invest  151.00  in Elicera Therapeutics AB on October 7, 2024 and sell it today you would earn a total of  23.00  from holding Elicera Therapeutics AB or generate 15.23% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Elicera Therapeutics AB  vs.  Idogen AB

 Performance 
       Timeline  
Elicera Therapeutics 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Elicera Therapeutics AB are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Elicera Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.
Idogen AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Idogen AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Idogen AB is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Elicera Therapeutics and Idogen AB Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Elicera Therapeutics and Idogen AB

The main advantage of trading using opposite Elicera Therapeutics and Idogen AB positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Elicera Therapeutics position performs unexpectedly, Idogen AB can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Idogen AB will offset losses from the drop in Idogen AB's long position.
The idea behind Elicera Therapeutics AB and Idogen AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Complementary Tools

Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Money Managers
Screen money managers from public funds and ETFs managed around the world